The pharmaceutical industry is at a critical juncture, urgently needing to transform towards sustainability to reduce its environmental footprint.
Sustainable biomanufacturing is a key focus within this context, primarily aiming to produce pharmaceutical products such as drugs, vaccines, and biologics using processes with minimal environmental impact.
This includes resource conservation, waste reduction and greenhouse gas (GHG) emissions reduction, renewable materials and energy deployment, and greener operations throughout the sourcing, manufacturing, and distribution processes.
Our research director Aarthi Janakiraman spoke to BioSpectrum India in depth about this latest trend.
Read more at: BioSpectrum India
